Press Releases Events & Presentations Event Details 47th Annual International Herpesvirus Workshop Jul 15 - Jul 19, 2023 Supporting Materials ABI-5366 - Pre-clinical characterization of ABI-5366: a highly potent long-acting helicase-primase inhibitor for the treatment of high recurrence genital herpes 522 KB ABI-5366 - Pre-clinical characterization of ABI-5366: a highly potent long-acting helicase-primase inhibitor for the treatment of high recurrence genital herpes (oral presentation) 1.1 MB Shareholder Tools Print Email Alerts Printed Materials RSS News Feeds Search Investors
47th Annual International Herpesvirus Workshop Jul 15 - Jul 19, 2023 Supporting Materials ABI-5366 - Pre-clinical characterization of ABI-5366: a highly potent long-acting helicase-primase inhibitor for the treatment of high recurrence genital herpes 522 KB ABI-5366 - Pre-clinical characterization of ABI-5366: a highly potent long-acting helicase-primase inhibitor for the treatment of high recurrence genital herpes (oral presentation) 1.1 MB
ABI-5366 - Pre-clinical characterization of ABI-5366: a highly potent long-acting helicase-primase inhibitor for the treatment of high recurrence genital herpes 522 KB
ABI-5366 - Pre-clinical characterization of ABI-5366: a highly potent long-acting helicase-primase inhibitor for the treatment of high recurrence genital herpes (oral presentation) 1.1 MB
